Sergio, Some long awaited great news from CMPDC today. Watch out for this one over the next several months.
Related Quotes
CMPDC
1 5/32
+11/32
delayed 20 mins - disclaimer
Friday October 8, 9:20 am Eastern Time
Company Press Release
SOURCE: CompuMed, Inc.
CompuMed Announces Favorable Beta Site Results for Automated OsteoGram(R) 2000
- Company Provides Update on Telemedicine Business Outlook -
LOS ANGELES, Oct. 8 /PRNewswire/ -- CompuMed, Inc. (Nasdaq: CMPDC - news) announced today that it has received favorable beta-site results from the operation of its Automated OsteoGram® 2000 Software at multiple clinical locations.
''Results from our beta-sites indicate that our Automated OsteoGram can diagnose osteoporosis with the highest degree of accuracy of any product on the market,'' stated Robert Goldberg, CompuMed Chairman and CEO. ''It requires only a simple hand X-ray that is interpreted by our Food and Drug Administration (FDA) approved software. Our goal is to make the Automated OsteoGram® 2000 the test of choice for osteoporosis testing among medical practitioners worldwide. We are looking forward to a successful product launch of the Automated OsteoGram during the first quarter of 2000,'' Goldberg added.
The Company also announced that its telemedicine business continues to post significant gains in revenues and new user placements. CompuMed recently awarded a purchase contract to a private OEM manufacturer for 300 new electrocardiogram (ECG) units and a new Central ECG Storage System that is considered state of the art. ''We believe our ECG processing revenue will increase significantly as a result of the placement of these new units in the balance of 1999 and 2000. The Central ECG Storage System will also enable CompuMed to pursue opportunities in the clinical research field,'' Goldberg commented.
CompuMed, based in Los Angeles, California, develops solutions to important medical problems through the use of computer technology. In addition to the Automated OsteoGram® 2000 and the developmental Digital OsteoView 2000, CompuMed has developed computer-aided telemedicine services for cardiology and currently provides on-line computer interpretation of electrocardiograms to physicians, government, and corporate health care providers.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks defined in this document. All such forward-looking statements whether written or oral, and whether made by or on behalf of the Company are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
Editors' note: This release is available on the Internet at compumed.net or noonanrusso.com.
SOURCE: CompuMed, Inc.
--------------------------------------------------------------------------------
More
|
